Indication

PIK3CA-related overgrowth spectrum

PIK3CA-related overgrowth spectrum (PROS) is a heterogeneous group of rare disorders caused by mosaic, postzygotic activating mutations in the *PIK3CA* gene, leading to hyperactivation of the PI3K/AKT/mTOR signaling pathway. Read more about PIK3CA-related overgrowth spectrum

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common PIK3CA-related overgrowth spectrum therapies.

Showing 1–2 of 2 drugs

VIJOICE (alpelisib)

ANTINEOPLASTIC - PHOSPHATIDYLINOSITOL 3-KINASE ALPHA INHIB.·PIK3CA-RELATED OVERGROWTH SPECTRUM
Novartis Pharmaceuticals

VIJOICE (alpelisib)

ANTINEOPLASTIC - PHOSPHATIDYLINOSITOL 3-KINASE ALPHA INHIB.·PIK3CA-RELATED OVERGROWTH SPECTRUM
Novartis Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with PIK3CA-related overgrowth spectrum preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About PIK3CA-related overgrowth spectrum.

PIK3CA-related overgrowth spectrum (PROS) is a heterogeneous group of rare disorders caused by mosaic, postzygotic activating mutations in the *PIK3CA* gene, leading to hyperactivation of the PI3K/AKT/mTOR signaling pathway.

Typically presenting congenitally or in early childhood, the condition is characterized by disproportionate, segmental, or focal overgrowth that can involve adipose tissue, skeletal structures, skin, brain, and the vascular system.

Defining clinical manifestations include asymmetric limb and trunk hypertrophy, complex vascular and lymphatic malformations, epidermal nevi, and central nervous system anomalies such as megalencephaly and cortical dysplasia.

The spectrum unifies several previously distinct clinical entities, including CLOVES syndrome, megalencephaly-capillary malformation (MCAP) syndrome, and isolated macrodactyly or fibroadipose hyperplasia.

Personalize your experience

Follow PIK3CA-related overgrowth spectrum and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it